Last Action | 01/05/21: to Committee on Committees (H) |
---|---|
Title | AN ACT relating to the establishment of emergency insulin programs and declaring an emergency. |
Bill Documents | Introduced |
Bill Request Number | 968 |
Sponsors | P. Minter, K. Flood, A. Scott, S. Westrom |
Summary of Original Version | Create various new sections of KRS Chapter 211 to define terms; establish the urgent-need insulin program and the continuing access to insulin program; establish eligibility guidelines for both programs; establish the application process; establish the process by which insulin is dispensed to eligible individuals; establish the responsibilities of insulin manufacturers for facilitating the dispensing of insulin to eligible individuals; establish the responsibilities of the Kentucky Board of Pharmacy for administering the program; require manufacturers to maintain privacy of all data obtained; require manufacturers to annually report certain information to the board; require the board to report certain information to the General Assembly upon request; establish penalties; EMERGENCY. |
Index Headings of Original Version |
Diseases - Diabetes, urgent-need insulin program and continuing access to insulin program, establishment Drugs and Medicines - Urgent-need insulin program and continuing access to insulin program, establishment Effective Dates, Emergency - Urgent-need insulin program and continuing access to insulin program, establishment Pharmacists - Urgent-need insulin program and continuing access to insulin program, establishment State Agencies - Board of Pharmacy, continuing access to insulin program State Agencies - Board of Pharmacy, urgent-need insulin program Administrative Regulations and Proceedings - Board of Pharmacy, continuing access to insulin program Administrative Regulations and Proceedings - Board of Pharmacy, urgent-need insulin program Boards and Commissions - Board of Pharmacy, continuing access to insulin program, establishment Boards and Commissions - Board of Pharmacy, urgent-need insulin program, establishment Reports Mandated - Insulin manufacturers, urgent-need and continuing access to insulin programs, requirement |
12/10/20 |
|
---|---|
01/05/21 |
|
Last updated: 11/9/2023 2:52 PM (EST)